In recent years, peptides in clinical applications have attracted enormous attention attributed to its unique properties such as high biological activity, high specificity and low toxicity. Currently, more than 400 peptide drugs are under clinical developments and over 60 are already approved for clinical use globally.

With its capability for small scale non-GMP custom peptides and commercial current good manufacturing practice (cGMP) manufacturing, Synbio Technologies can provide high quality peptide which meet the requirements of all stages of pharmaceutical peptide development from research to commercialization. We provide flexible batch sizes from small scale to large scale manufacturing including synthesis, purification, and lyophilization.